537 related articles for article (PubMed ID: 33685080)
1. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
[No Abstract] [Full Text] [Related]
2. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins.
Zeng Y; Li Z; Shang J; Kang Y
Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106
[TBL] [Abstract][Full Text] [Related]
3. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
4. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
8. PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.
Wang J; Yuan X; Wang Y; Zhang Y; Han M; Lu H; Liu S; Zhang Y; Ge F; Liu Y; Cheng J
Virus Res; 2024 Mar; 341():199326. PubMed ID: 38253259
[TBL] [Abstract][Full Text] [Related]
9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
11. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
Tang L; An P; Zhao Q; Winkler CA; Chang J; Guo JT
J Virol; 2023 Jan; 97(1):e0126122. PubMed ID: 36519896
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
13. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA.
Nkongolo S; Nußbaum L; Lempp FA; Wodrich H; Urban S; Ni Y
Antiviral Res; 2019 Aug; 168():146-155. PubMed ID: 31018112
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C.
Li J; Li J; Chen S; Yuan Q; Zhang J; Wu J; Jiang Q; Wang Q; Xia NS; Zhang J; Tong S
Gut; 2021 Mar; 70(3):575-584. PubMed ID: 32571971
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Hepatitis B virus cccDNA replication by siRNA.
Li GQ; Gu HX; Li D; Xu WZ
Biochem Biophys Res Commun; 2007 Apr; 355(2):404-8. PubMed ID: 17300745
[TBL] [Abstract][Full Text] [Related]
16. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
[TBL] [Abstract][Full Text] [Related]
18.
Tu T; Zehnder B; Qu B; Urban S
JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatitis B virus gene expression by small interfering RNAs targeting cccDNA and X antigen.
Xie Q; Zhang S; Wang W; Li YM; Du T; Su XL; Wei YQ; Deng HX
Acta Virol; 2012; 56(1):49-55. PubMed ID: 22404609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
